{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:30:22Z","timestamp":1792114222975,"version":"4.4.0"},"reference-count":90,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1843,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1111\/j.1365-2893.2010.01353.x","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T04:30:53Z","timestamp":1281933053000},"page":"749-756","source":"Crossref","is-referenced-by-count":139,"title":["Natural history and treatment of chronic delta hepatitis"],"prefix":"10.1111","volume":"17","author":[{"given":"C.","family":"Yurdayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Idilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Bozdayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,15]]},"reference":[{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gut.18.12.997","article-title":"Immunofluorescence detection of new antigen-antibody system (delta\/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers","volume":"18","author":"Rizzetto","year":"1977","journal-title":"Gut"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB2|cit2","first-page":"1235","volume-title":"Fundamental Virology","author":"Taylor","year":"1996"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000024977","article-title":"Hepatitis delta virus","volume":"42","author":"Taylor","year":"1999","journal-title":"Intervirology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1016\/S0168-8278(03)00331-3","article-title":"Delta hepatitis: an update","volume":"39","author":"Farci","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1126\/science.1129308","article-title":"A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene","volume":"313","author":"Salehi-Ashtiani","year":"2006","journal-title":"Science"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0168-8278(97)80004-9","article-title":"Decrease in HDV endemicity in Italy","volume":"26","author":"Sagnelli","year":"1997","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/jhep.2000.17711","article-title":"Chronic hepatitis D: a vanishing Disease? An Italian multicenter study","volume":"32","author":"Gaeta","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1440-1746.1997.tb00364.x","article-title":"Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors","volume":"12","author":"Huo","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1478-3231.2008.01673.x","article-title":"Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis","volume":"28","author":"De\u011fertekin","year":"2008","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.21590","article-title":"Hepatitis D virus infection- not a vanishing disease in Europe!","volume":"45","author":"Wedemeyer","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.21816","article-title":"Hepatitis delta in Europe: vanishing or refreshing?","volume":"46","author":"Gaeta","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.21652","article-title":"Hepatitis D virus infection: not a vanishing disease in Europe!","volume":"45","author":"Le Gal","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jmv.21078","article-title":"The increasing prevalence of hepatitis delta virus infection in Southern London","volume":"80","author":"Cross","year":"2008","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/141.5.590","article-title":"Transmission of hepatitis B virus-associated delta antigen in chimpanzees","volume":"141","author":"Rizzetto","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/infdis\/151.5.925","article-title":"Hepatitis B virus-associated coinfection and superinfection with \u2202 agent: indistinguishable disease with different outcome","volume":"151","author":"Caredda","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(82)90156-8","article-title":"Influence of delta infection on severity of hepatitis B","volume":"ii","author":"Smedile","year":"1982","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0016-5085(84)80153-5","article-title":"Fulminant B viral hepatitis: role of delta agent","volume":"86","author":"Govindarajan","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB18|cit18","first-page":"267","article-title":"Course and prognosis of acute HDV patients","volume":"364","author":"Caredda","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB19|cit19","first-page":"157","article-title":"Advances in hepatitis D virus biology and disease","volume":"12","author":"Smedile","year":"1994","journal-title":"Prog Liver Dis"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/0003-4819-98-4-437","article-title":"Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen","volume":"98","author":"Rizzetto","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(88)80457-4","article-title":"Chronic HDV hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease","volume":"6","author":"Negro","year":"1988","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/JVI.71.3.2241-2251.1997","article-title":"Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles","volume":"71","author":"Nisini","year":"1997","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","article-title":"Cytotoxic CD4+ T cells in viral hepatitis","volume":"13","author":"Aslan","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2004.01.011","article-title":"Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection","volume":"126","author":"Liaw","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB26|cit26","first-page":"145","article-title":"The natural history of chronic delta hepatitis","volume":"234","author":"Bonino","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.1840080631","article-title":"Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees","volume":"8","author":"Ponzetto","year":"1988","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/hep.1840130305","article-title":"Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D","volume":"13","author":"Smedile","year":"1991","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2006.01.035","article-title":"Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients","volume":"130","author":"Su","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0676.1989.tb00389.x","article-title":"Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection","volume":"9","author":"Lin","year":"1989","journal-title":"Liver"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/JVI.78.5.2537-2544.2004","article-title":"Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades","volume":"78","author":"Radjef","year":"2004","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/JCM.02142-07","article-title":"Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in Cental Africa","volume":"46","author":"Makuwa","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/viro.1997.8644","article-title":"Geographic distribution and genetic variability of hepatitis delta virus genotype I","volume":"234","author":"Shakil","year":"1997","journal-title":"Virology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/174.5.920","article-title":"Hepatitis B virus (HBV)\/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon Basin: the roles of genotype III and HBV genotype F","volume":"174","author":"Casey","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(95)91558-3","article-title":"Genotyping of hepatitis D with restriction-fragment length polymorphism and relation to outcome of hepatitis D","volume":"346","author":"Wu","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9071(199606)49:2<145::AID-JMV12>3.0.CO;2-D","article-title":"Characterization of a new genotype II hepatitis delta virus from Taiwan","volume":"49","author":"Lee","year":"1996","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1099\/vir.0.19499-0","article-title":"Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease","volume":"84","author":"Watanabe","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/598955","article-title":"Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus","volume":"199","author":"Kiesslich","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/jhep.2002.31777","article-title":"Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0006-291X(03)01076-3","article-title":"Initiation of RNA replication of cloned Taiwan-3 isolate of hepatitis delta virus genotype II in cultured cells","volume":"306","author":"Lin","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0016-5085(99)70563-9","article-title":"Changing pattern of chronic hepatitis D in southern Europe","volume":"117","author":"Rosina","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A 28-year study of the course of hepatitis D infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(85)80766-2","article-title":"Delta hepatitis-present status","volume":"1","author":"Rizzetto","year":"1985","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.46.3.420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B","volume":"46","author":"Fattovich","year":"2000","journal-title":"Gut"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1056\/NEJM199401133300202","article-title":"Treatment of chronic hepatitis D with interferon alfa-2a","volume":"330","author":"Farci","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.1840190602","article-title":"Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response","volume":"19","author":"Madejon","year":"1994","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0676.1995.tb00106.x","article-title":"The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial","volume":"15","author":"Gaudin","year":"1995","journal-title":"Liver"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/j.gastro.2004.03.017","article-title":"Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis","volume":"126","author":"Farci","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/jhep.2003.50148","article-title":"Long-term supression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy","volume":"37","author":"Lampertico","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0016-5085(99)70409-9","article-title":"Resolution of chronic delta hepatitis after 12\u2003years of interferon alfa therapy","volume":"117","author":"Lau","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2893.1996.tb00002.x","article-title":"Long-term interferon-alfa treatment of children with chronic hepatitis delta: a multicentre study","volume":"3","author":"Di Marco","year":"1996","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2893.2007.00875.x","article-title":"A pilot study of two years of interferon in patients with chronic delta hepatitis","volume":"14","author":"Yurdayd\u0131n","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/135965350501000603","article-title":"Two-year interferon therapy with or without ribavirin in chronic delta hepatitis","volume":"10","author":"G\u00fcnsar","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.21296","article-title":"Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta","volume":"44","author":"Niro","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1478-3231.2006.01279.x","article-title":"Treatment of chronic hepatitis delta with pegylated interferon-alpha2b","volume":"26","author":"Erhardt","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/hep.21325","article-title":"Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up","volume":"44","author":"Castelnau","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0168-8278(07)61602-X","article-title":"72\u2003week data of the HIDIT-1 trial: multicenter randomized study comparing peginterferon \u03b1-2a plus adefovir vs. peginterferon \u03b1-2a plus placebo vs. adefovir in chronic delta hepatitis (abstr.)","volume":"46","author":"Wedemeyer","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2893.2007.00936.x","article-title":"Treatment of chronic delta hepatitis with lamivudine vs. lamivudine + interferon vs. interferon","volume":"15","author":"Yurdaydin","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB59|cit59","first-page":"119","article-title":"Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study","volume":"24","author":"Marzano","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB60|cit60","first-page":"223","article-title":"Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes","volume":"364","author":"Rasshofer","year":"1991","journal-title":"Prog Clin Biol Res"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0676.1994.tb00065.x","article-title":"Ribavirin treatment for chronic hepatitis D: a pilot study","volume":"14","author":"Garripoli","year":"1994","journal-title":"Liver"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.510300217","article-title":"Lamivudine for chronic delta hepatitis","volume":"30","author":"Lau","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2036.2005.02542.x","article-title":"Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study","volume":"22","author":"Niro","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00162-9","article-title":"Famciclovir treatment of chronic delta hepatitis","volume":"37","author":"Yurdayd\u0131n","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB65|cit65","first-page":"735A","article-title":"Entecavir may be beneficial in a subset of patients with chronic delta hepatitis (abstr.)","volume":"50","author":"\u00d6nder","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB66|cit66","first-page":"722A","article-title":"Treatment of HBeAg-positive chronic delta hepatitis with nucleos(t)ide analogs (abstr.)","volume":"48","author":"Yurdayd\u0131n","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB67|cit67","first-page":"1184A","article-title":"HBeAg-positive chronic delta hepatitis: virological, biochemical and clinical features in a large European data base (abstr.)","volume":"48","author":"Heidrich","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/jhep.2001.20899","article-title":"Antiviral activity of clevudine[L-FMAU,(1-(2-fluoro-5-methyl-\u03b2,L-arabinofuranosyluracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax)","volume":"33","author":"Peek","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1128\/AAC.49.10.4396-4399.2005","article-title":"Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks","volume":"49","author":"Casey","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jhep.2009.04.019","article-title":"Clevudine myopathy in patients with chronic hepatitis B","volume":"51","author":"Kim","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-2893.2000.00254.x","article-title":"Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus","volume":"7","author":"Wolters","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1746.2006.04082.x","article-title":"Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial","volume":"21","author":"Canbakan","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.49.3.1135-1138.2005","article-title":"Alpha interferon and ribavirin combination therapy of chronic hepatitis D","volume":"49","author":"Kaymako\u011flu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1478-3231.2009.02140.x","article-title":"Quantitative HBsAg and HDV RNA levels in chronic delta hepatitis","volume":"30","author":"Zachou","year":"2010","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/135965350701200307","article-title":"Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring","volume":"12","author":"Manesis","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/hep.22760","article-title":"Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alpha-2a in HBeAg-negative chronic hepatitis B","volume":"49","author":"Brunetto","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1590-8658(02)80149-9","article-title":"Treatment of chronic hepatitis D with thymus-derived polypeptide thymic humoral factor-gamma 2: a pilot study","volume":"34","author":"Rosina","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.7326\/0003-4819-98-6-1024_1","article-title":"Levamisole and chronic delta hepatitis","volume":"98","author":"Arrigoni","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB79|cit79","first-page":"13","article-title":"Shutting the door on hepatitis delta virus: sensitivity to prenylation inhibition prompts new therapeutic strategy","volume":"5","author":"Glenn","year":"1999","journal-title":"Viral Hepat Rev"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/hep.21112","article-title":"Characterization of a hepatitis B and hepatitis delta virus receptor binding site","volume":"43","author":"Engelke","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparin sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(98)00525-0","article-title":"\u03b1-Glucosidase inhibitors as potential broad based anti-viral agents","volume":"430","author":"Mehta","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","article-title":"Hepatitis B virus pre-S mutants, endoplasmic reticulum stres and hepatocarcinogenesis","volume":"97","author":"Wang","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2007.06.048","article-title":"The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome","volume":"369","author":"Liu","year":"2007","journal-title":"Virology"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.1598578","article-title":"Identification of a prenylation site in delta virus large antigen","volume":"256","author":"Glenn","year":"1992","journal-title":"Science"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1128\/JVI.72.11.9303-9306.1998","article-title":"Use of a prenylation inhibitor as a novel antiviral agent","volume":"72","author":"Glenn","year":"1998","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1128\/JVI.76.20.10465-10472.2002","article-title":"A prenylation inhibitor prevents production of infectious hepatitis delta virus particles","volume":"76","author":"Bordier","year":"2002","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI17704","article-title":"In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus","volume":"112","author":"Bordier","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2893.2010.01353.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1200\/JCO.1999.17.11.3631","article-title":"Ras protein farnesyltransferase: a strategic target for anticancer therapeutic development","volume":"17","author":"Rowinsky","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01353.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2010.01353.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T15:28:05Z","timestamp":1711726085000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2010.01353.x"}},"subtitle":["Chronic delta hepatitis"],"short-title":[],"issued":{"date-parts":[[2010,8,15]]},"references-count":90,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01353.x","relation":{},"ISSN":["1352-0504"],"issn-type":[{"value":"1352-0504","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,15]]}}}